Article: STUDY SHOWS NEW INVESTIGATIONAL CORTICOSTEROID SPRAY DECREASES HAY FEVER SYMPTOMS IN YOUNG CHILDREN

NEW ORLEANS, March 19 /PRNewswire/ -- A new investigational once-daily water-based nasal spray, Nasacort AQ (triamcinolone acetonide), can safely and effectively treat hay fever symptoms in patients as young as six years of age, according to the results of a new study presented today at the 52nd Annual Meeting of the American Academy of Allergy, Asthma, and Immunology.

Hay fever -- also called seasonal allergic rhinitis -- is a common health problem, affecting approximately 22 million Americans of all ages.

The new data showed that Nasacort AQ, a nasally inhaled corticosteroid, relieves hay fever symptoms caused by an allergy to grass pollen in children ranging from six to ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!